GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Adastra Holdings Ltd (OTCPK:XTXXF) » Definitions » Capex-to-Revenue

XTXXF (Adastra Holdings) Capex-to-Revenue : 0.00 (As of Sep. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Adastra Holdings Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Adastra Holdings's Capital Expenditure for the three months ended in Sep. 2024 was $0.00 Mil. Its Revenue for the three months ended in Sep. 2024 was $5.24 Mil.

Hence, Adastra Holdings's Capex-to-Revenue for the three months ended in Sep. 2024 was 0.00.


Adastra Holdings Capex-to-Revenue Historical Data

The historical data trend for Adastra Holdings's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adastra Holdings Capex-to-Revenue Chart

Adastra Holdings Annual Data
Trend Apr19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
- 0.73 0.10 0.05 0.03

Adastra Holdings Quarterly Data
Apr19 Oct19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.03 -0.02 0.04 -

Competitive Comparison of Adastra Holdings's Capex-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Adastra Holdings's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adastra Holdings's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Adastra Holdings's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Adastra Holdings's Capex-to-Revenue falls into.


;
;

Adastra Holdings Capex-to-Revenue Calculation

Adastra Holdings's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-0.508) / 16.565
=0.03

Adastra Holdings's Capex-to-Revenue for the quarter that ended in Sep. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 5.244
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Adastra Holdings  (OTCPK:XTXXF) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Adastra Holdings Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Adastra Holdings's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Adastra Holdings Business Description

Traded in Other Exchanges
Address
275th Street, Suite 5451, Langley, BC, CAN, V4W 3X8
Adastra Holdings Ltd is an extraction and processing solutions company. It aims to develop and deploy large-scale cannabis and hemp extraction technologies and provide turnkey processing solutions to help licensed standard and micro-cultivators maximize the value of every harvest. The company has two operating segments comprised of manufacturing and non-manufacturing operations. The manufacturing operations include the manufacturing, sale, and distribution of cannabis-related products, and the non-manufacturing operations include PerceiveMD.